Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management

Submitted: 6 June 2014
Accepted: 6 June 2014
Published: 6 June 2014
Abstract Views: 2279
PDF: 1521
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The high prevalence of emotional disorders (anxiety, chronic stress, mood depression) in patients with pain during rheumatologic diseases (particularly fibromyalgia) is closely related to the common pathogenic mechanisms concerning emotions and pain. Therefore a prompt identification of any psychic component of pain, also by means of specific tools, is a must, because it can require an adjustment of the therapeutic approach by combining both an analgesic treatment and antidepressants and/or psychotherapeutic strategies.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Torta, R., Pennazio, F., & Ieraci, V. (2014). Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management. Reumatismo, 66(1), 92–97. https://doi.org/10.4081/reumatismo.2014.769